# ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study

> **NCT03395236** · PHASE4 · COMPLETED · sponsor: **Spectranetics Corporation** · enrollment: 49 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **COMBINATION_PRODUCT:** StellarexTM 0.014" Over-The-Wire Drug-coated Angioplasty Balloon

## Key facts

- **NCT ID:** NCT03395236
- **Lead sponsor:** Spectranetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-20
- **Primary completion:** 2023-08-23
- **Final completion:** 2023-08-23
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03395236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03395236, "ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03395236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*